CT及MRI对原发性肝癌经导管肝动脉化疗栓塞术后疗效评估的对比

发布时间：2018-01-30 02:42

本文关键词： 原发性肝癌经导管肝动脉化疗栓塞 CT MRI　出处：《实用医学杂志》2017年18期 　论文类型：期刊论文

【摘要】：目的比较CT及MRI对原发性肝癌经导管肝动脉化疗栓塞(TACE)术后疗效评估的价值。方法以45例原发性肝癌患者为研究对象,入选患者均采用TACE治疗3~5次,治疗后行CT、MRI病灶检查及数字减影血管造影检查,以数字减影血管造影检查作为比较标准,分析CT及MRI检查的病灶残余或病灶复发结果及肿瘤病灶包膜检出情况。结果 TACE术后病灶残余或病灶复发的扫描准确率和扫描敏感性方面,CT扫描显著低于MRI扫描,差异具有统计学意义(P0.05);TACE术后肿瘤包膜检出率方面,CT扫描显著低于MRI扫描,差异具有统计学意义(P0.05);TACE术后不同类型碘油沉积病灶残余或病灶复发的检出率方面,CT扫描显著低于MRI扫描,差异具有统计学意义(P0.05)。结论与CT检查方式比较,MRI检测在TACE术后病灶残余或病灶复发有着较高的的准确率和敏感性,不仅可有效显示肿瘤包膜情况,也检测出不同类型碘油沉积的病灶残余或病灶复发,MRI对原发性肝癌TACE术后的疗效评估优于CT对原发性肝癌TACE术后的疗效评估。
[Abstract]:Objective to compare the value of CT and MRI in evaluating the curative effect of transcatheter hepatic artery chemoembolization (TACEE) for primary liver cancer. All the patients were treated with TACE for 5 times. After the treatment, the focus of TACE and digital subtraction angiography were examined, and digital subtraction angiography was taken as the comparative standard. Results the accuracy and sensitivity of CT and MRI in the detection of residual or recurrent lesions and the detection of tumor capsule were analyzed. Results the accuracy and sensitivity of CT and MRI in detecting residual lesions or recurrence of lesions were analyzed. Ct scan was significantly lower than MRI scan, the difference was statistically significant (P 0.05). The detection rate of tumor capsule after TACE was significantly lower than that of MRI, and the difference was statistically significant (P 0.05). The detection rate of residual or recurrence of different types of lipiodol deposits after TACE was significantly lower than that of MRI. Conclusion compared with CT, MRI has a higher accuracy and sensitivity in detecting residual or recurrent lesions after TACE. Not only can the tumor capsule be effectively displayed, but also the residual or recurrent lesions of different types of lipiodol deposits can be detected. MRI was better than CT in evaluating the curative effect of TACE for primary liver cancer.
【作者单位】：四川省医学科学院·四川省人民医院放射科;
【分类号】：R445.2;R730.44;R735.7
【正文快照】： 原发性肝癌是继胃癌和食管癌后的第三大恶性肿瘤,全球年新增病例可高达60万人,我国的原发性肝癌占比世界的50%以上,是严重威胁我国人民生命安全的疾病[1]。原发性肝癌具有明显症状时一般都处于中晚期,且此时80%的患者均已不适合手术切除治疗和化疗,经导管肝动脉化疗栓塞(TACE)

【相似文献】